Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tohen

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Schizophrenia Research|March 22, 2003
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sampleT J Miller, R B Zipursky, D Perkins, et al.
The American Journal of Psychiatry|May 18, 1999
Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study GroupM Tohen, T M Sanger, S L McElroy, et al.
Acta Psychiatrica Scandinavica|June 23, 2015
Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite studyL Tondo, G H Vázquez, C Baethge, et al.
Journal of Child and Adolescent Psychopharmacology|October 20, 2001
A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorderJ A Frazier, J Biederman, M Tohen, et al.
International Journal of Bipolar Disorders|January 3, 2023
A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early interventionA Ratheesh, D Hett, J Ramain, et al.
Acta Psychiatrica Scandinavica|June 26, 2014
Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force ReportF Kapczinski, P V S Magalhães, V Balanzá-Martinez, et al.
Acta Psychiatrica Scandinavica|June 27, 2015
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorderS L McElroy, D E Kemp, E S Friedman, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Schizophrenia Research|March 22, 2003
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sampleT J Miller, R B Zipursky, D Perkins, et al.
The American Journal of Psychiatry|May 18, 1999
Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study GroupM Tohen, T M Sanger, S L McElroy, et al.
Acta Psychiatrica Scandinavica|June 23, 2015
Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite studyL Tondo, G H Vázquez, C Baethge, et al.
Journal of Child and Adolescent Psychopharmacology|October 20, 2001
A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorderJ A Frazier, J Biederman, M Tohen, et al.
International Journal of Bipolar Disorders|January 3, 2023
A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early interventionA Ratheesh, D Hett, J Ramain, et al.
Acta Psychiatrica Scandinavica|June 26, 2014
Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force ReportF Kapczinski, P V S Magalhães, V Balanzá-Martinez, et al.
Acta Psychiatrica Scandinavica|June 27, 2015
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorderS L McElroy, D E Kemp, E S Friedman, et al.
Pageof 13